The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes with metastasis-directed therapy (MDT) and fixed-duration systemic therapy in oligometastatic hormone-sensitive prostate cancer (omHSPC).
 
Praful Ravi
No Relationships to Disclose
 
Jiaming Huang
No Relationships to Disclose
 
Wanling Xie
Consulting or Advisory Role - Convergent Therapeutics
 
Bridget Whelpley
No Relationships to Disclose
 
Emma Kelly
No Relationships to Disclose
 
Bradley Alexander McGregor
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Genentech/Roche; Merck; Pfizer; Seattle Genetics/Astellas
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Exelixis (Inst); Pfizer/EMD Serono (Inst); Seattle Genetics/Astellas (Inst)
 
Xiao X. Wei
Honoraria - OncLive
Consulting or Advisory Role - Novartis
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Corvus Pharmaceuticals
 
Kerry L. Kilbridge
Research Funding - American Cancer Society/Pfizer
 
Srinivas Raghavan Viswanathan
No Relationships to Disclose
 
Mary-Ellen Taplin
Honoraria - Abbvie; Arcus Biosciences; Arvinas; AstraZeneca; Blue Earth Diagnostics; Clovis Oncology; Constellation Pharmaceuticals; Epizyme; Hengrui Therapeutics; Janssen-Ortho; Pfizer; Propella Therapeutics; Research to Practice; Roivant; Targeted Oncology; UpToDate
Consulting or Advisory Role - Arcus Ventures (I); AstraZeneca; Bayer; Best Doctors, Inc; Clovis Oncology; Janssen-Ortho; Myovant Sciences; Pfizer; Research to Practice; UpToDate
Research Funding - Janssen-Ortho (Inst)
Travel, Accommodations, Expenses - Advanced Prostate Cancer Society
 
Christopher Sweeney
Stock and Other Ownership Interests - Leuchemix
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Genentech/Roche; Janssen Biotech; Lilly; Pfizer; POINT Biopharma; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Dendreon; Janssen Biotech (Inst); Pfizer (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Leuchemix, Parthenolide, Dimethylaminoparthenolide. Exelixis: Abiraterone plus cabozantinib combination
 
Martin T. King
No Relationships to Disclose
 
Mai Anh Huynh
No Relationships to Disclose
 
Atish Dipankar Choudhury
Employment - LeMaitre Vascular (I)
Honoraria - Aptitude Health; Bayer; Cancer Network; Clinical Care Options; Great Debates and Updates; Journal of Clinical Pathways/Oncology Learning Network; Journal of Clinical Pathways/Oncology Learning Network; OncLive; Pfizer; Targeted Oncology
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bayer; Blackstone; Blue Earth Diagnostics; Clovis Oncology; Dendreon; Janssen Oncology; Lilly; MedaCorp; Tolmar
Research Funding - Bayer; Janssen (Inst)
Travel, Accommodations, Expenses - Genentech